Drug intelligence / Profile preview

IST003

Development stage: Unknown
Lead developer: Istesso

Overview

IST003 is a drug candidate developed by Istesso Ltd. It is currently in the discovery phase of development. The drug is being investigated for its potential in treating immune system diseases, including autoimmune diseases, and fibrosis. The specific mechanism of action and modality of IST003 have not been publicly detailed.

Targets

ND1 (Mitochondrial electron transport chain complex I)

Beyond the preview

Go deeper on IST003.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IST003.

Explore the full profile